December 6, 2011 — W. L. Gore & Associates, Inc. (Gore) has received U.S. Food and Drug Administration (FDA) approval for new diameter sizes of the contralateral leg component of its Excluder AAA Endoprosthesis.


After spending a week walking the show floor and meeting with scores of vendors at the Radiological Society of North America (RSNA) 2011 annual meeting, the following are my choices for the most innovative new technologies presented.

December 5, 2011 – Roche announced that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market.

December 5, 2011 – The U.S. Food and Drug Administration (FDA) approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).

December 5, 2011 – New study shows significant increase in quality of life (QoL) among overweight patients following ablation of atrial fibrillation (AF), compared to patients with a lower body mass index (BMI) where no substantial improvement was observed.  The study, published in the December edition of HeartRhythm, the official journal of the Heart Rhythm Society, reveals an association between BMI and a change in QoL between the pre- and postablation periods in a large AF patient cohort.  The study also verifies comparable procedural success rates of ablation in both overweight and lean patients. 

December 5, 2011 – NASA has signed a patent license agreement that will allow a California company use of NASA-developed technology that could be used to treat hardened arteries in the heart.

 

December 5, 2011 – University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance…just not as they originally thought.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now